A Rare Case of New-Onset Ulcerative Colitis following Initiation of Secukinumab
Secukinumab is an IgG monoclonal antibody widely used for treatment of ankylosing spondylitis, psoriasis, and psoriatic arthritis. Recently, there has been increasing controversy regarding potential adverse effects of the drug especially in those with underlying inflammatory bowel disease. We presen...
Saved in:
Main Authors: | Ted George Achufusi, Prateek S. Harnee, Sekou Rawlins |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/2975631 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New-Onset Ulcerative Colitis in a Young Caucasian Woman with Unclassified Arteritis
by: Bryan Roberts
Published: (2022-01-01) -
Cerebral Venous Thrombosis as an Initial Presentation of Ulcerative Colitis
by: Hiroshi Yamazaki, et al.
Published: (2022-01-01) -
Severe and Extensive Enteritis following Colectomy for Ulcerative Colitis
by: Greg Rosenfeld, et al.
Published: (2012-01-01) -
Atypical Distribution of Inflammation in Newly Diagnosed Ulcerative Colitis is not Rare
by: Sang Hyoung Park, et al.
Published: (2014-01-01) -
Exacerbation of Ulcerative Colitis following Administration of 5-ASA Enemas
by: Barbara A. Young, et al.
Published: (1989-01-01)